Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression | Clinical Cancer Research https://t.co/2ZIboKRbx6
28 followers
17 followers
RT @MarieWislez: 💪ALK+ pts 1L-alectinib, 27% had TP53 comutation and a worse #prognosis. Proteasome Inhibition Overcomes #ALK-TKI Resistanc…
505 followers
RT @MarieWislez: 💪ALK+ pts 1L-alectinib, 27% had TP53 comutation and a worse #prognosis. Proteasome Inhibition Overcomes #ALK-TKI Resistanc…
3,024 followers
RT @MarieWislez: 💪ALK+ pts 1L-alectinib, 27% had TP53 comutation and a worse #prognosis. Proteasome Inhibition Overcomes #ALK-TKI Resistanc…